Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-04-09
1982-06-01
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3356, G01N 3358
Patent
active
043327850
ABSTRACT:
The reticulocyte content present in a specimen of red blood cells is quantitatively measured based upon the selective immunoreactivity of the reticulocyte portion of the specimen with a reticulocyte-specific antibody which is immunoreactive with proteinaceous material associated with reticulocytes but not associated with mature red blood cells. Such immunoreactive proteinaceous material may be transferrin, transferrin receptor, transcobalamin II, or transcobalamin II receptor. Various procedures are described for quantitating such selective immunoreactivity, including fluorescent and radioactive detection techniques employing direct or indirect fluorescent or radioactive labeling of the reticulocyte-specific antibody.
REFERENCES:
patent: 4082085 (1978-04-01), Wardlaw et al.
patent: 4146604 (1979-03-01), Kleinerman
patent: 4273757 (1981-06-01), Selhub et al.
Allen Robert H.
Seligman Paul A.
Alpert A. Sidney
Koffsky David N.
Nucker Christine M.
Teplitz Jerome M.
University Patents Inc.
LandOfFree
Immunoassay for measurement of reticulocytes, and immunoreactive does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for measurement of reticulocytes, and immunoreactive, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for measurement of reticulocytes, and immunoreactive will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849393